These anecdotal reports come with obvious limitations
Oxidative stress and changes in antioxidative defense system in erythrocytes of preeclampsia in women
Lund Rasmussen C, Klee Olsen M, Thit Johnsen A, et al
c-MET/HGF-targeted therapy such as the specific inhibitor SU11274 would be promising in at least a subset of SCLC patients with deregulated c-MET signalling through its overexpression or activating mutations
It incorporates key modifications, including 14E/17R mutations to stabilize an -helical segment via a salt bridge, multiple proline substitutions (25P, 28P, 29P) to reduce -sheet formation, and N-terminal C20 fatty diacid lipidation for reversible albumin binding (Kruse et al
Toxicity studies with 5-hydroxymethylfurfural and its metabolite 5-sulphooxymethylfurfural in wild-type mice and Transgenic mice expressing human sulphotransferases 1A1 and 1A2